Here’s Why These Five Stocks Are in Spotlight

On the other hand, shares of Mylan Inc. (NASDAQ:MYL) have slid by 4% on the back of reports that two senior lawmakers questioned the company in connection with the price increases for EpiPens, injectable devices used to counter allergic reactions. In a letter sent to Mylan Inc. (NASDAQ:MYL) CEO, Heather Bresch, Senator Chuck Grassley requested information regarding the pricing process of EpiPens. Meanwhile, Sen. Amy Klobuchar, the top Democrat on the U.S. Senate’s Judiciary Committee’s antitrust subcommittee, has urged the Federal Trade Commission to investigate the price increase of a pack of two EpiPens to $500 from $100 in 2008, according to news reports. A total of 44 funds from our database were long Mylan at the end of June, down from 51 a quarter earlier.

Stocks of Mobileye NV (NYSE:MBLY) and Delphi Automotive PLC (NYSE:DLPH) are trading higher today after the companies have announced that they will develop a fully-automated driving vehicle solution, which should be production-ready for 2019. Mobileye NV (NYSE:MBLY) will use its expertise of real-time mapping, while Delphi Automotive PLC (NYSE:DLPH) will contribute with sensors, LiDAR and radar, as well as software. “This partnership will allow us to give our customers an increased level of automated capabilities faster and more cost effective,” Kevin Clark, Delphi’s CEO, said in a statement. A total of 25 investors from our database held shares of Mobileye NV (NYSE:MBLY) and 30 investors had long positions in Delphi Automotive PLC (NYSE:DLPH) heading into the third quarter.

Disclosure: None